A team led by the Rutgers Institute for Translational Medicine and Science that includes Princeton University and the New Jersey Institute of Technology has received a National Institutes of Health grant for $29 million over five years for joining the NIH’s Clinical and Translational Science Awards Program.
In a statement Rutgers said that the CTSA program at Rutgers University will be known as NJ ACTS: New Jersey Alliance for Clinical and Translational Science. Additional funding from the institutions will grow the program to about $45 million.
Translational science takes observations made in the laboratory, clinic and community and creates interventions that improve the health of individuals and populations – from diagnostics and therapeutics to medical procedures and behavioral interventions.
“The ultimate goal is bringing more evidence-based treatments to more patients more quickly,” said Reynold Panettieri, vice chancellor for translational medicine and science and director of Rutgers Institute for Translational Medicine and Science, in a statement.
NIH supports a national network of more than 50 CTSAs at medical research institutions nationwide that collaborate to speed the translation of research discoveries into improved patient care. It enables research teams, including scientists, patient advocacy organizations and community members, to tackle system-wide scientific and operational problems in clinical and translational research that no one team can overcome.
The grant will allow Rutgers and its partners to train and cultivate the translational science workforce; engage patients and communities in every phase of the translational process; promote the integration of special and underserved populations in translational research across the human lifespan; innovate processes to increase the quality and efficiency of translational research, particularly of multisite trials; and advance the use of big data information systems.
The collaborative program develops innovative approaches to barriers in clinical research, such as the efficient recruitment of research participants and approvals for multisite clinical trials.
The grant was awarded due to the strength of RITMS, the alliance between Rutgers Biomedical and Health Sciences, Princeton and NJIT, and the partnerships with community-based organizations, hospitals, community health centers, outpatient practices, data centers and health information exchanges. It reaches nearly seven million of the state’s nine million residents.